Targeting T-bet for Prevention of Graft-Versus-Host Disease and Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective therapeutic option for many malignant diseases. However, the efficacy of allo-HSCT is limited by the occurrence of destructive graft-versus-host disease (GVHD). Since allogeneic T cells are the driving force in the develo...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
Scholar Commons
2015
|
| Subjects: | |
| Online Access: | http://scholarcommons.usf.edu/etd/5828 http://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=7024&context=etd |